Clinical immunology · NHS Bands 2–8

Immunology interview questions and training for NHS biomedical scientists

Virtual immunology laboratory, LIMS workflows, autoimmunity panel interpretation, flow cytometry, and primary / secondary immunodeficiency reference, aligned to ISO 15189:2022 and UKAS standards.

Reviewed by Desmond O., HCPC-registered Biomedical Scientist, and the PathologyLabTraining editorial team

ISO 15189:2022
UK NEQAS aligned
ICAP ANA pattern nomenclature
Bench simulation

Virtual immunology laboratory suite

Immersive laboratory experience across 19 workstations: immunofluorescence microscopy, ELISA automation, complement testing, transplant immunology and specialised assays.

Virtual Immunology Lab Suite is available to premium subscribers and trial users.

LIMS

Immunology LIMS

Advanced laboratory information management for immunology with cross-departmental references and complete validation workflow.

Immunology LIMS System is available to premium subscribers and trial users.

Autoantibody work-up

Autoimmunity analysis

Interactive tools for autoantibody screening, ANA / ENA / ANCA patterns, and clinical interpretation with disease associations.

Antinuclear Antibody (ANA) Patterns

Common immunofluorescence patterns and their clinical significance

Homogeneous

Uniform staining of nucleus; associated with SLE and drug-induced lupus

Speckled

Fine or coarse speckles throughout nucleus; seen in SLE, MCTD, and Sjögren's

Nucleolar

Clumpy staining of nucleoli; associated with systemic sclerosis

Centromere

Discrete speckles; highly specific for limited cutaneous systemic sclerosis (lcSSc)

Laboratory Insight

Pattern recognition should be followed by specific extractable nuclear antigen (ENA) testing to identify the exact autoantibody specificity. The immunofluorescence pattern provides important initial diagnostic clues.

Cellular immunology

Flow cytometry guide

Immunophenotyping, gating strategies and clinical applications of flow cytometry in diagnosis: the depth Band 6+ panels expect.

Flow Cytometry Principles

Core concepts of flow cytometry in clinical immunology

Key Components

Flow cytometry analyses multiple characteristics of individual cells simultaneously by suspending cells in a stream of fluid and passing them through an electronic detection apparatus.

Fluidics System

  • Creates stream of single cells
  • Hydrodynamic focusing aligns cells
  • Ensures cells pass through laser one by one
  • Controls sample flow rate
  • Managed through sheath fluid pressure

Optics System

  • Lasers excite fluorochromes
  • Optical filters select specific wavelengths
  • Forward scatter measures cell size
  • Side scatter assesses cell granularity
  • Fluorescence detects specific antibody binding

Electronic System

The electronic system converts light signals into electronic signals that can be processed by a computer. The process involves:

Signal detection
Amplification
Analog-to-digital conversion
Data storage
Analysis

Fluorochromes

Commonly used fluorochromes in clinical immunology applications:

FITC
(Green)
PE
(Orange ~575nm)
PerCP
(Tandem Red ~675nm)
APC
(Far Red)
Pacific Blue
(Blue)
PE-Cy7
(Red/IR)
FITC-Alexa
(Green)
BUV
(UV)
PID & SID

Immunodeficiency guide

Reference for primary and secondary immunodeficiencies with diagnostic pathways and laboratory findings.

Primary Immunodeficiency Disorders

Genetic disorders affecting immune system development and function

Classification Approach

Primary immunodeficiencies (PIDs) are classified based on the affected component of the immune system. They result from genetic mutations affecting immune system development or function.

Severe Combined Immunodeficiency (SCID)

Definition

Group of disorders characterised by severe defects in T cell development, with variable B and NK cell defects.

Key Features
  • Profound lymphopenia (especially T cells)
  • Recurrent severe infections beginning in early infancy
  • Failure to thrive
  • Chronic diarrhoea
  • Can present with skin rash (maternal T cell engraftment)
Common Subtypes
PhenotypeGenetic DefectInheritance
T-B-NK+RAG1/2, DCLRE1CAR
T-B-NK-ADAAR
T-B+NK-IL2RGX-linked
T-B+NK+IL7R, CD3 chainsAR

Antibody Deficiencies

Common Disorders
  • X-linked agammaglobulinaemia (BTK deficiency)
  • Common Variable Immunodeficiency (CVID)
  • Selective IgA Deficiency
  • Specific antibody deficiency
  • Hyper-IgM syndrome
Clinical Presentation
  • Recurrent sinopulmonary infections
  • Gastrointestinal infections and disorders
  • Autoimmunity (especially in CVID)
  • Increased risk of malignancy
  • Onset typically after 6 months when maternal antibody wanes
CVID Diagnostic Criteria
  1. Age > 4 years
  2. Low IgG and low IgA and/or IgM
  3. Poor response to vaccines
  4. Exclusion of secondary causes

Phagocytic Disorders

Key Disorders
  • Chronic Granulomatous Disease (NADPH oxidase defects)
  • Leukocyte Adhesion Deficiency (CD18, selectin defects)
  • Chediak-Higashi Syndrome (LYST mutations)
Clinical Features
  • Recurrent bacterial and fungal infections
  • Abscesses, pneumonia, osteomyelitis
  • Poor wound healing
  • Gingivitis and periodontitis
  • Granuloma formation (in CGD)
Diagnostic Tests
  • DHR or NBT test for CGD
  • Flow cytometry for CD18 expression in LAD
  • Peripheral blood smear for giant granules in CHS
  • Genetic testing

Complement Deficiencies

Pathway Defects
  • Classical pathway (C1q, C2, C4): Autoimmunity, immune complex disease
  • Alternative pathway (Factor D, properdin): Neisserial infections
  • Terminal pathway (C5-C9): Recurrent meningococcal infections
  • Regulatory proteins (C1-INH): Hereditary angioedema
Clinical Associations
  • SLE-like syndrome (early pathway defects)
  • Recurrent bacterial infections (especially encapsulated)
  • Neisserial infections (terminal pathway)
  • Angioedema (C1-INH deficiency)
Diagnostic Approach
  • CH50 (classical pathway activity)
  • AP50 (alternative pathway activity)
  • Individual complement component quantification
  • Genetic testing
Reference values

Immunology data visualisation

Interactive charts and graphs showcasing key immunological parameters and antibody patterns.

Autoantibody Prevalence in Autoimmune Diseases

Illustrative, approximate percentages for teaching only. Reported positivity varies widely by cohort, disease stage and assay.

Key Clinical Insights:

  • Anti-dsDNA or anti-Sm antibodies score 6 points (counted once) in the 2019 EULAR/ACR classification criteria for SLE (Aringer et al., 2019), which require an ANA titre of at least 1:80 on HEp-2 cells as the entry criterion
  • Anti-Sm antibodies are highly specific for SLE but are found in only a minority of patients
  • Anti-CCP antibodies are more specific than rheumatoid factor for RA: a meta-analysis reported pooled sensitivity of 67% and specificity of 95% (Nishimura et al., Ann Intern Med 2007)
  • Anti-Ro (SSA) is the predominant autoantibody marker in Sjögren's syndrome
  • Anti-Scl-70 (anti-topoisomerase I) is associated with the diffuse cutaneous form of systemic sclerosis
  • Cross-reactivity between diseases reflects shared pathogenic pathways
Foundations

Immunology quick guide

Essential knowledge areas for immunology, from foundational concepts to specialised techniques.

Innate Immunity

The first line of defence against pathogens

Components of Innate Immunity

Innate immunity represents the body's first line of defence against pathogens, characterised by rapid, non-specific responses that do not confer long-lasting protection.

Physical & Chemical Barriers

  • Epithelial surfaces

    Skin and mucous membranes form tight junctions to prevent pathogen entry.

  • Mucociliary clearance

    Mucus entraps pathogens while cilia propel them out of the respiratory tract.

  • Antimicrobial peptides

    Defensins, cathelicidins disrupt microbial membranes. Found in skin, gut, lungs.

  • Chemical defences

    Gastric acid, lysozyme, low pH of skin, vaginal secretions.

Cellular Components

  • Neutrophils

    First cells to migrate to infection sites; phagocytose and destroy pathogens.

  • Monocytes/Macrophages

    Tissue phagocytes; clear debris, present antigens, secrete cytokines.

  • Dendritic cells

    Professional antigen-presenting cells bridging innate and adaptive immunity.

  • NK cells

    Detect and kill virus-infected cells and tumour cells without prior sensitisation.

  • Mast cells & Basophils

    Release histamine and other mediators; important in allergic responses.

Pattern Recognition

Innate immune cells recognise pathogens through Pattern Recognition Receptors (PRRs) that bind to Pathogen-Associated Molecular Patterns (PAMPs), conserved structures present on microbes but not host cells.

Key PRR Families:
  • Toll-like receptors (TLRs)

    Cell surface (TLR1, 2, 4, 5, 6) and endosomal (TLR3, 7, 8, 9) receptors.

  • NOD-like receptors (NLRs)

    Cytoplasmic sensors forming inflammasomes when activated.

  • RIG-I-like receptors (RLRs)

    Detect viral RNA in cytoplasm.

  • C-type lectin receptors

    Recognise carbohydrate structures on pathogens.

Common PAMPs:
  • Lipopolysaccharide (LPS)

    Gram-negative bacterial cell wall component; activates TLR4.

  • Peptidoglycan

    Bacterial cell wall component; activates TLR2.

  • Flagellin

    Bacterial flagella protein; activates TLR5.

  • Double-stranded RNA

    Viral replication intermediate; activates TLR3.

  • CpG DNA

    Unmethylated bacterial DNA motifs; activate TLR9.

Complement System

The complement system is a cascade of plasma proteins that enhance (complement) antibody function and innate immunity through pathogen opsonisation, inflammatory response stimulation, and direct pathogen lysis.

Classical Pathway
  • Activated by antigen-antibody complexes
  • C1q binds Fc region of antibodies
  • Activates C1r and C1s proteases
  • C4 and C2 cleavage forms C3 convertase
  • Links adaptive and innate immunity
Alternative Pathway
  • Activated by microbial surfaces
  • Spontaneous C3 hydrolysis ("tickover")
  • Factor B and D form C3 convertase
  • Properdin stabilises the convertase
  • Rapid response without antibodies
Lectin Pathway
  • Initiated by mannose-binding lectin
  • Recognises carbohydrates on microbes
  • Activates MASP proteases (like C1r/C1s)
  • Cleaves C4 and C2
  • Independent of antibodies
Terminal Pathway Functions:
OpsonisationC3b deposits on pathogen surfaces, enhancing phagocytosis
InflammationC3a, C5a anaphylatoxins recruit leukocytes and induce inflammation
Membrane Attack ComplexC5b-9 forms pores in cell membranes leading to lysis

Clinical Relevance

  • Defects in innate immunity components typically present with recurrent bacterial infections
  • Chronic granulomatous disease (NADPH oxidase defects) causes impaired neutrophil killing
  • Complement deficiencies associate with specific infection patterns and autoimmune diseases
  • Pattern recognition receptor polymorphisms influence susceptibility to infectious diseases
  • Excessive innate immune activation contributes to inflammatory and autoimmune conditions

Sources and guidance

This hub's content aligns with the UK's professional and regulatory references for the specialty: